Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...
Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...
Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...
A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...
Protease hypersensitivity leaves lasting immune memory in lung tissue, influencing future inflammation. Read more.
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...
BELLEVUE, WA, UNITED STATES, April 10, 2026 /EINPresswire.com/ -- Realogics Sotheby’s International Realty (RSIR) ...
Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...
Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results